BIOMAT Database Logo BIOMAT Database Logo

[Etiological diagnosis of pleural effusion. Is hyaluronic acid a parameter of biological interest?]. 1980

A Boersma, and P Degand, and G Biserte

Hyaluronic acid was detected in 193 of 5 359 pleural effusions. The chromatographic determination of H.A distinguished different rage levels: in the 5-50 mg/l range 61% of the cases had mesothelioma, whilst levels over 50 mg/l. 82 per cent had mesothelioma.

UI MeSH Term Description Entries
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006820 Hyaluronic Acid A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Amo Vitrax,Amvisc,Biolon,Etamucine,Healon,Hyaluronan,Hyaluronate Sodium,Hyvisc,Luronit,Sodium Hyaluronate,Acid, Hyaluronic,Hyaluronate, Sodium,Vitrax, Amo

Related Publications

A Boersma, and P Degand, and G Biserte
[The etiological diagnosis of pleural effusion].
June 1997, Revista clinica espanola,
A Boersma, and P Degand, and G Biserte
Etiological diagnosis of pleural effusion by pleural biopsy.
July 1955, Journal of the American Medical Association,
A Boersma, and P Degand, and G Biserte
Role of pleural biopsy in etiological diagnosis of pleural effusion.
October 2010, Lung India : official organ of Indian Chest Society,
A Boersma, and P Degand, and G Biserte
Hyaluronic acid in viscous malignant mesothelioma pleural effusion.
January 2021, Respirology case reports,
A Boersma, and P Degand, and G Biserte
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
December 2013, Lung cancer (Amsterdam, Netherlands),
A Boersma, and P Degand, and G Biserte
[Etiological study of pleural effusion].
December 1979, Revista clinica espanola,
A Boersma, and P Degand, and G Biserte
[Etiological distribution of pleural effusion].
May 1978, La Revue du praticien,
A Boersma, and P Degand, and G Biserte
[Pleural effusion--which diagnosis is significant?].
January 2007, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
A Boersma, and P Degand, and G Biserte
Biological markers in the diagnosis of tuberculous pleural effusion.
February 2017, Annales de biologie clinique,
A Boersma, and P Degand, and G Biserte
[Hyaluronic acid in pleural fluids: an additional parameter for clinical diagnosis on diffuse mesotheliomas (author's transl)].
January 1979, Archiv fur Geschwulstforschung,
Copied contents to your clipboard!